Clinical Trial Update: Procollagen-3 Driven Corticosteroids for Persistent Acute Respiratory Distress Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial of procollagen-3 driven corticosteroids for persistent acute respiratory distress syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Procollagen-3 driven corticosteroids

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Persistent ARDS | Phase 3 | Status: TERMINATED